Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1212 | 2782 | 48.8 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
410 | 3 | HEAT SHOCK PROTEIN//HSP90//HSP70 | 29410 |
290 | 2 | HEAT SHOCK PROTEIN//HSP90//HSP70 | 18900 |
1212 | 1 | HSP90//GELDANAMYCIN//HSP90 INHIBITORS | 2782 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HSP90 | authKW | 2712182 | 22% | 41% | 602 |
2 | GELDANAMYCIN | authKW | 1236253 | 7% | 55% | 205 |
3 | HSP90 INHIBITORS | authKW | 1200358 | 5% | 71% | 153 |
4 | HEAT SHOCK PROTEIN 90 | authKW | 793839 | 7% | 39% | 185 |
5 | 17 AAG | authKW | 709091 | 4% | 63% | 102 |
6 | CDC37 | authKW | 298370 | 2% | 63% | 43 |
7 | RADICICOL | authKW | 257847 | 2% | 50% | 47 |
8 | 17 DMAG | authKW | 234341 | 1% | 69% | 31 |
9 | CO CHAPERONE | authKW | 226681 | 2% | 41% | 50 |
10 | CLIENT PROTEINS | authKW | 217962 | 1% | 83% | 24 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5156 | 24% | 0% | 656 |
2 | Biochemistry & Molecular Biology | 4941 | 37% | 0% | 1024 |
3 | Cell Biology | 3732 | 20% | 0% | 559 |
4 | Chemistry, Medicinal | 3699 | 11% | 0% | 317 |
5 | Pharmacology & Pharmacy | 411 | 10% | 0% | 269 |
6 | Chemistry, Organic | 335 | 7% | 0% | 184 |
7 | Biophysics | 226 | 4% | 0% | 122 |
8 | Hematology | 119 | 3% | 0% | 79 |
9 | Genetics & Heredity | 82 | 4% | 0% | 105 |
10 | Biochemical Research Methods | 81 | 3% | 0% | 78 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC UK CANC THER EUT | 113207 | 2% | 22% | 47 |
2 | SIGNAL TRANSDUCT MOL PHARMACOL TEAM | 92723 | 0% | 65% | 13 |
3 | SECT STRUCT BIOL | 88539 | 2% | 19% | 43 |
4 | PROGRAM MOL PHARMACOL CHEM | 81805 | 1% | 23% | 33 |
5 | UROL ONCOL BRANCH | 75505 | 3% | 10% | 70 |
6 | HADDOW S | 49841 | 1% | 13% | 36 |
7 | PHARMACEUT OPT SPECT | 43893 | 0% | 67% | 6 |
8 | MOL BIOL COURSE | 32923 | 0% | 100% | 3 |
9 | GUANGZHOU JINAN BIOMED DEV | 32233 | 0% | 24% | 12 |
10 | PROT FOLDING GRP | 29262 | 0% | 67% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL STRESS & CHAPERONES | 18684 | 2% | 4% | 44 |
2 | MOLECULAR CANCER THERAPEUTICS | 4919 | 2% | 1% | 43 |
3 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 3228 | 1% | 1% | 26 |
4 | JOURNAL OF BIOLOGICAL CHEMISTRY | 2829 | 7% | 0% | 207 |
5 | CLINICAL CANCER RESEARCH | 2656 | 2% | 0% | 61 |
6 | CURRENT CANCER DRUG TARGETS | 2570 | 1% | 2% | 15 |
7 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2206 | 3% | 0% | 73 |
8 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1595 | 1% | 1% | 26 |
9 | JOURNAL OF MEDICINAL CHEMISTRY | 1401 | 2% | 0% | 54 |
10 | ADVANCES IN CANCER RESEARCH | 1297 | 0% | 1% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HSP90 | 2712182 | 22% | 41% | 602 | Search HSP90 | Search HSP90 |
2 | GELDANAMYCIN | 1236253 | 7% | 55% | 205 | Search GELDANAMYCIN | Search GELDANAMYCIN |
3 | HSP90 INHIBITORS | 1200358 | 5% | 71% | 153 | Search HSP90+INHIBITORS | Search HSP90+INHIBITORS |
4 | HEAT SHOCK PROTEIN 90 | 793839 | 7% | 39% | 185 | Search HEAT+SHOCK+PROTEIN+90 | Search HEAT+SHOCK+PROTEIN+90 |
5 | 17 AAG | 709091 | 4% | 63% | 102 | Search 17+AAG | Search 17+AAG |
6 | CDC37 | 298370 | 2% | 63% | 43 | Search CDC37 | Search CDC37 |
7 | RADICICOL | 257847 | 2% | 50% | 47 | Search RADICICOL | Search RADICICOL |
8 | 17 DMAG | 234341 | 1% | 69% | 31 | Search 17+DMAG | Search 17+DMAG |
9 | CO CHAPERONE | 226681 | 2% | 41% | 50 | Search CO+CHAPERONE | Search CO+CHAPERONE |
10 | CLIENT PROTEINS | 217962 | 1% | 83% | 24 | Search CLIENT+PROTEINS | Search CLIENT+PROTEINS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JACKSON, SE , (2013) HSP90: STRUCTURE AND FUNCTION.MOLECULAR CHAPERONES. VOL. 328. ISSUE . P. 155-240 | 209 | 56% | 53 |
2 | KHANDELWAL, A , CROWLEY, VM , BLAGG, BSJ , (2016) NATURAL PRODUCT INSPIRED N-TERMINAL HSP90 INHIBITORS: FROM BENCH TO BEDSIDE?.MEDICINAL RESEARCH REVIEWS. VOL. 36. ISSUE 1. P. 92 -118 | 127 | 78% | 6 |
3 | TREPEL, J , MOLLAPOUR, M , GIACCONE, G , NECKERS, L , (2010) TARGETING THE DYNAMIC HSP90 COMPLEX IN CANCER.NATURE REVIEWS CANCER. VOL. 10. ISSUE 8. P. 537 -549 | 102 | 65% | 568 |
4 | SOLAROVA, Z , MOJZIS, J , SOLAR, P , (2015) HSP90 INHIBITOR AS A SENSITIZER OF CANCER CELLS TO DIFFERENT THERAPIES.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 46. ISSUE 3. P. 907 -926 | 161 | 66% | 8 |
5 | KHAN, S , BOURBOULIA, D , TREPEL, JB , NECKERS, L , MOLLAPOUR, M , WALTON-DIAZ, A , (2013) CONTRIBUTIONS OF CO-CHAPERONES AND POST-TRANSLATIONAL MODIFICATIONS TOWARDS HSP90 DRUG SENSITIVITY.FUTURE MEDICINAL CHEMISTRY. VOL. 5. ISSUE 9. P. 1059 -1071 | 123 | 92% | 20 |
6 | WHITESELL, L , LINDQUIST, SL , (2005) HSP90 AND THE CHAPERONING OF CANCER.NATURE REVIEWS CANCER. VOL. 5. ISSUE 10. P. 761-772 | 95 | 69% | 1223 |
7 | LI, J , SOROKA, J , BUCHNER, J , (2012) THE HSP90 CHAPERONE MACHINERY: CONFORMATIONAL DYNAMICS AND REGULATION BY CO-CHAPERONES.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1823. ISSUE 3. P. 624-635 | 129 | 64% | 123 |
8 | PRATT, WB , TOFT, DO , (2003) REGULATION OF SIGNALING PROTEIN FUNCTION AND TRAFFICKING BY THE HSP90/HSP70-BASED CHAPERONE MACHINERY.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 228. ISSUE 2. P. 111-133 | 149 | 51% | 908 |
9 | MATTS, RL , MANJARREZ, JR , (2009) ASSAYS FOR IDENTIFICATION OF HSP90 INHIBITORS AND BIOCHEMICAL METHODS FOR DISCRIMINATING THEIR MECHANISM OF ACTION.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 15. P. 1462-1478 | 149 | 82% | 8 |
10 | LI, YY , ZHANG, T , SCHWARTZ, SJ , SUN, DX , (2009) NEW DEVELOPMENTS IN HSP90 INHIBITORS AS ANTI-CANCER THERAPEUTICS: MECHANISMS, CLINICAL PERSPECTIVE AND MORE POTENTIAL.DRUG RESISTANCE UPDATES. VOL. 12. ISSUE 1-2. P. 17-27 | 129 | 79% | 78 |
Classes with closest relation at Level 1 |